Mohammed Asmal, MD PhD
ORBIMED HEALTHCARE FUND MANAGEMENT
Entrepreneur in Residence
Deus Bazira, DrPH, MPH, MBA
GEORGETOWN UNIVERSITY, WASHINGTON D.C., USA
Co-director Center for Global Health Practice & Impact
David Brittan, MD
ALBERTS STEM CELL TRANSPLANT CENTER, PRETORIA, SOUTH AFRICA
Head of Center
Michael Chang, MPH
Adjuvant Capital
Principal
Kenneth Cornetta, MD
INDIANA UNIVERSITY, INDIANAPOLIS, USA
Professor of Clinical Medical & Molecular Genetics
Chris Danek, PhD, MBA
CATHOLIC UNIVERSITY OF AMERICA, WASHINGTON D.C., USA
Distinguished Fellow and CEO, Bessel LLC
Lynda Dee, JD
AIDS ACTION BALTIMORE
Executive Director
Steven Deeks, MD
UNIVERSITY OF CALIFORNIA SAN FRANCISCO, USA
Professor of Medicine
Dimitri (Mitko) Dimitriov, PhD
UNIVERSITY OF PITTSBURGH, USA
Professor of Medicine
Aaron Dominguez, PhD
Catholic University of America, Washington D.C., USA
Provost
Stephanie Farnia, MPH
Nimitt Consulting (Health policy partners)
Principal
Bryon Johnson, PhD
MEDICAL COLLEGE OF WISCONSIN, MILWAUKEE, USA
Professor, Pediatrics (Hem/Onc), Micro. & Immunology
Sadik Kassim, PhD
VOR BIOPHARMA, CAMBRIDGE, MASSACHUSETTS, USA
Chief Technology Officer
Dominic Kemps, LLM, MSc, MA, MSc
SOMMARTEL LTD.
Chief Executive Officer
Hans-Peter Kiem, MD PhD
FRED HUTCH CANCER CENTER, SEATTLE, USA
Professor, Director, Stem Cell and Gene Therapy Program, Clinical Research Division
Cissy Kityo, MD
Joint Clinical Research Center, Kampala, Uganda
Executive Director
Sharon Lewin, FRACP, PHD, FAAHMS
THE PETER DOHERTY INSTITUTE, MELBOURNE, AUSTRALIA
Director of Institute
Marcos de Lima, MD
Ohio State University Medical Center, Columbus, USA
Division Chief, Hematology & Oncology
Vikram Matthews, MD
Christian Medical College, Vellore, India
Professor of Hematology
Adrian McKemey, PhD
IQVIA, San Diego, USA
Managing Director and Head of R&D Strategy Solutions
John Mellors, MD
University of Pittsburgh, USA
Professor of Medicine, Chair for Global Elimination of HIV/AIDS
David Miklos, MD, PhD
Stanford University, Palo Alto, USA
Chief of Bone Marrow Transplantation
Sam Murphy, PhD
SALUBRIUS BIOTHERAPEUTICS
Chief Executive Officer
Matthew Porteus, MD, PhD
Stanford University, Palo Alto, USA
Professor of Pediatrics
Florian Schuster, MBA
Bit Bio, Cambridge, UK
Chief Operating and Financial Officer
Rafick-Pierre Sekaly, PhD
Emory University, Atlanta, USA
Vice-Chair of Translational Medicine, Department of Pathology
Nirali N. Shah, MD, MHSc
NATIONAL CANCER INSTITUTE, BETHESDA, USA
Head, Hematologic Malignancies Section, Pediatric Oncology Branch
Jeff Sheehy
San Francisco, California, USA
Former CIRM Board Member & Patient Advocate
Elizabeth J Shpall, MD
MD Anderson Cancer Center, Houston, USA
Deputy Chair, Department of Stem Cell Transplantation and Cellular Therapy
John F. Tisdale, M.D.
NATIONAL INSTITUTES OF HEALTH
Senior Investigator and Director
Els Verhoeyen, PhD
ENS DE LYON, UNIVERSITY OF LYON, LYON & UNIVERSITY CôTE D’AZUR, NICE, FRANCE
Professor, INSERM Research Director
Michael Maschan, MD PhD
DMITRY ROGACHEV NATIONAL MEDICAL RESEARCH CENTRE FOR PEDIATRIC HEMATOLOGY, ONCOLOGY AND IMMUNOLOGY, MOSCOW, RUSSIA
Director of the Department of Hematopoietic Stem Cell Transplantation